category	term	number_of_genes	number_of_genes_in_background	ncbiTaxonId	inputGenes	preferredNames	p_value	fdr	description
COMPARTMENTS	GOCC:0005737	43	7871	9606	YBX3,OAS3,NMI,NDUFA10,RYDEN,SQOR,UBE2L6,ERAP1,NLRP6,TYMS,NAPG,MX2,RAP1GDS1,OAS2,TAP1,PARP9,STAT1,PTGS2,TPM3,DPP7,IFIT1,IFIT3,IFIT2,TAP2,ATG2A,RTN3,ISG15,ASPH,DDX58,SAMD9,TRIM22,STT3A,SYNPO,SIL1,MX1,IFITM3,OAS1,IFI35,PARP14,MRPS14,PALLD,EIF4G2,AIFM2	YBX3,OAS3,NMI,NDUFA10,C19orf66,SQRDL,UBE2L6,ERAP1,NLRP6,TYMS,NAPG,MX2,RAP1GDS1,OAS2,TAP1,PARP9,STAT1,PTGS2,TPM3,DPP7,IFIT1,IFIT3,IFIT2,TAP2,ATG2A,RTN3,ISG15,ASPH,DDX58,SAMD9,TRIM22,STT3A,SYNPO,SIL1,MX1,IFITM3,OAS1,IFI35,PARP14,MRPS14,PALLD,EIF4G2,AIFM2	8.46e-07	0.002	Cytoplasm
COMPARTMENTS	GOCC:0005829	24	2919	9606	YBX3,OAS3,NMI,UBE2L6,ERAP1,NLRP6,TYMS,MX2,RAP1GDS1,STAT1,TPM3,IFIT1,IFIT3,ISG15,DDX58,SAMD9,SYNPO,MX1,OAS1,IFI35,PARP14,PALLD,EIF4G2,AIFM2	YBX3,OAS3,NMI,UBE2L6,ERAP1,NLRP6,TYMS,MX2,RAP1GDS1,STAT1,TPM3,IFIT1,IFIT3,ISG15,DDX58,SAMD9,SYNPO,MX1,OAS1,IFI35,PARP14,PALLD,EIF4G2,AIFM2	2.21e-06	0.0026	Cytosol
COMPARTMENTS	GOCC:0110165	57	13853	9606	YBX3,OAS3,NMI,DSTN,NDUFA10,RYDEN,IPO8,SP110,SQOR,SAMHD1,CAPN5,UBE2L6,IGFBP7,ITGA2,ERAP1,NLRP6,TYMS,NAPG,HNRNPM,SLC41A3,PHF6,MX2,RAP1GDS1,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,TPM3,DPP7,IFIT1,IFIT3,IFIT2,TAP2,ATG2A,RTN3,ISG15,ASPH,DDX58,SAMD9,TRIM22,STT3A,SYNPO,SIL1,MX1,IFITM3,OAS1,IFI35,HELZ2,PARP14,PTK7,MRPS14,PALLD,EIF4G2,LIN7A,AIFM2	YBX3,OAS3,NMI,DSTN,NDUFA10,C19orf66,IPO8,SP110,SQRDL,SAMHD1,CAPN5,UBE2L6,IGFBP7,ITGA2,ERAP1,NLRP6,TYMS,NAPG,HNRNPM,SLC41A3,PHF6,MX2,RAP1GDS1,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,TPM3,DPP7,IFIT1,IFIT3,IFIT2,TAP2,ATG2A,RTN3,ISG15,ASPH,DDX58,SAMD9,TRIM22,STT3A,SYNPO,SIL1,MX1,IFITM3,OAS1,IFI35,HELZ2,PARP14,PTK7,MRPS14,PALLD,EIF4G2,LIN7A,AIFM2	2.82e-06	0.0026	Cellular anatomical entity
COMPARTMENTS	GOCC:0005622	50	11202	9606	YBX3,OAS3,NMI,NDUFA10,RYDEN,IPO8,SP110,SQOR,SAMHD1,UBE2L6,ERAP1,NLRP6,TYMS,NAPG,HNRNPM,PHF6,MX2,RAP1GDS1,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,TPM3,DPP7,IFIT1,IFIT3,IFIT2,TAP2,ATG2A,RTN3,ISG15,ASPH,DDX58,SAMD9,TRIM22,STT3A,SYNPO,SIL1,MX1,IFITM3,OAS1,IFI35,HELZ2,PARP14,MRPS14,PALLD,EIF4G2,AIFM2	YBX3,OAS3,NMI,NDUFA10,C19orf66,IPO8,SP110,SQRDL,SAMHD1,UBE2L6,ERAP1,NLRP6,TYMS,NAPG,HNRNPM,PHF6,MX2,RAP1GDS1,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,TPM3,DPP7,IFIT1,IFIT3,IFIT2,TAP2,ATG2A,RTN3,ISG15,ASPH,DDX58,SAMD9,TRIM22,STT3A,SYNPO,SIL1,MX1,IFITM3,OAS1,IFI35,HELZ2,PARP14,MRPS14,PALLD,EIF4G2,AIFM2	1.64e-05	0.0095	Intracellular
COMPARTMENTS	GOCC:0043231	39	7476	9606	YBX3,OAS3,NMI,NDUFA10,RYDEN,IPO8,SP110,SQOR,SAMHD1,ERAP1,TYMS,NAPG,HNRNPM,PHF6,MX2,RAP1GDS1,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,DPP7,IFIT3,IFIT2,TAP2,RTN3,ISG15,ASPH,TRIM22,STT3A,SIL1,MX1,IFITM3,IFI35,HELZ2,MRPS14,PALLD,AIFM2	YBX3,OAS3,NMI,NDUFA10,C19orf66,IPO8,SP110,SQRDL,SAMHD1,ERAP1,TYMS,NAPG,HNRNPM,PHF6,MX2,RAP1GDS1,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,DPP7,IFIT3,IFIT2,TAP2,RTN3,ISG15,ASPH,TRIM22,STT3A,SIL1,MX1,IFITM3,IFI35,HELZ2,MRPS14,PALLD,AIFM2	2.47e-05	0.0114	Intracellular membrane-bounded organelle
COMPARTMENTS	GOCC:0043227	42	8685	9606	YBX3,OAS3,NMI,NDUFA10,RYDEN,IPO8,SP110,SQOR,SAMHD1,CAPN5,ERAP1,TYMS,NAPG,HNRNPM,PHF6,MX2,RAP1GDS1,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,DPP7,IFIT3,IFIT2,TAP2,RTN3,ISG15,ASPH,DDX58,TRIM22,STT3A,SYNPO,SIL1,MX1,IFITM3,IFI35,HELZ2,MRPS14,PALLD,AIFM2	YBX3,OAS3,NMI,NDUFA10,C19orf66,IPO8,SP110,SQRDL,SAMHD1,CAPN5,ERAP1,TYMS,NAPG,HNRNPM,PHF6,MX2,RAP1GDS1,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,DPP7,IFIT3,IFIT2,TAP2,RTN3,ISG15,ASPH,DDX58,TRIM22,STT3A,SYNPO,SIL1,MX1,IFITM3,IFI35,HELZ2,MRPS14,PALLD,AIFM2	5.56e-05	0.0214	Membrane-bounded organelle
COMPARTMENTS	GOCC:0042825	2	3	9606	TAP1,TAP2	TAP1,TAP2	9.14e-05	0.0279	TAP complex
COMPARTMENTS	GOCC:0043226	45	9848	9606	YBX3,OAS3,NMI,DSTN,NDUFA10,RYDEN,IPO8,SP110,SQOR,SAMHD1,CAPN5,ERAP1,TYMS,NAPG,HNRNPM,PHF6,MX2,RAP1GDS1,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,TPM3,DPP7,IFIT3,IFIT2,TAP2,RTN3,ISG15,ASPH,DDX58,TRIM22,STT3A,SYNPO,SIL1,MX1,IFITM3,OAS1,IFI35,HELZ2,MRPS14,PALLD,AIFM2	YBX3,OAS3,NMI,DSTN,NDUFA10,C19orf66,IPO8,SP110,SQRDL,SAMHD1,CAPN5,ERAP1,TYMS,NAPG,HNRNPM,PHF6,MX2,RAP1GDS1,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,TPM3,DPP7,IFIT3,IFIT2,TAP2,RTN3,ISG15,ASPH,DDX58,TRIM22,STT3A,SYNPO,SIL1,MX1,IFITM3,OAS1,IFI35,HELZ2,MRPS14,PALLD,AIFM2	8.44e-05	0.0279	Organelle
COMPARTMENTS	GOCC:0043229	43	9242	9606	YBX3,OAS3,NMI,NDUFA10,RYDEN,IPO8,SP110,SQOR,SAMHD1,ERAP1,TYMS,NAPG,HNRNPM,PHF6,MX2,RAP1GDS1,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,TPM3,DPP7,IFIT3,IFIT2,TAP2,RTN3,ISG15,ASPH,DDX58,TRIM22,STT3A,SYNPO,SIL1,MX1,IFITM3,OAS1,IFI35,HELZ2,MRPS14,PALLD,AIFM2	YBX3,OAS3,NMI,NDUFA10,C19orf66,IPO8,SP110,SQRDL,SAMHD1,ERAP1,TYMS,NAPG,HNRNPM,PHF6,MX2,RAP1GDS1,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,TPM3,DPP7,IFIT3,IFIT2,TAP2,RTN3,ISG15,ASPH,DDX58,TRIM22,STT3A,SYNPO,SIL1,MX1,IFITM3,OAS1,IFI35,HELZ2,MRPS14,PALLD,AIFM2	0.00011	0.0286	Intracellular organelle
COMPARTMENTS	GOCC:0005783	10	825	9606	ERAP1,RAP1GDS1,TAP1,PTGS2,IFIT2,TAP2,RTN3,ASPH,STT3A,SIL1	ERAP1,RAP1GDS1,TAP1,PTGS2,IFIT2,TAP2,RTN3,ASPH,STT3A,SIL1	0.0002	0.0441	Endoplasmic reticulum
COMPARTMENTS	GOCC:0098844	2	5	9606	MX2,MX1	MX2,MX1	0.00019	0.0441	Postsynaptic endocytic zone membrane
COMPARTMENTS	GOCC:0001725	3	36	9606	TPM3,SYNPO,PALLD	TPM3,SYNPO,PALLD	0.00023	0.0442	Stress fiber
Process	GO:0034340	14	72	9606	OAS3,RYDEN,SAMHD1,MX2,OAS2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM3,OAS1,IFI35	OAS3,C19orf66,SAMHD1,MX2,OAS2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM3,OAS1,IFI35	4.68e-21	6.01e-17	Response to type i interferon
Process	GO:0051607	17	210	9606	OAS3,RYDEN,SAMHD1,MX2,OAS2,PARP9,STAT1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1	OAS3,C19orf66,SAMHD1,MX2,OAS2,PARP9,STAT1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1	1.62e-19	8.79e-16	Defense response to virus
Process	GO:0060337	13	67	9606	OAS3,SAMHD1,MX2,OAS2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM3,OAS1,IFI35	OAS3,SAMHD1,MX2,OAS2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM3,OAS1,IFI35	1.37e-19	8.79e-16	Type i interferon signaling pathway
Process	GO:0009615	18	293	9606	OAS3,RYDEN,SAMHD1,MX2,OAS2,PARP9,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1	OAS3,C19orf66,SAMHD1,MX2,OAS2,PARP9,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1	1.23e-18	3.16e-15	Response to virus
Process	GO:0045087	20	703	9606	OAS3,NMI,RYDEN,SAMHD1,NLRP6,MX2,OAS2,PARP9,STAT1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,PARP14	OAS3,NMI,C19orf66,SAMHD1,NLRP6,MX2,OAS2,PARP9,STAT1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,PARP14	1.72e-14	3.67e-11	Innate immune response
Process	GO:0044419	29	1899	9606	OAS3,NMI,RYDEN,SP110,SAMHD1,ITGA2,ERAP1,NLRP6,MX2,OAS2,TAP1,PARP9,STAT1,PTGS2,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,TAP2,RTN3,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,PARP14	OAS3,NMI,C19orf66,SP110,SAMHD1,ITGA2,ERAP1,NLRP6,MX2,OAS2,TAP1,PARP9,STAT1,PTGS2,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,TAP2,RTN3,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,PARP14	2.69e-14	4.93e-11	Interspecies interaction between organisms
Process	GO:0051707	24	1256	9606	OAS3,NMI,RYDEN,SAMHD1,ERAP1,NLRP6,MX2,OAS2,PARP9,STAT1,PTGS2,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,PARP14	OAS3,NMI,C19orf66,SAMHD1,ERAP1,NLRP6,MX2,OAS2,PARP9,STAT1,PTGS2,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,PARP14	1.05e-13	1.69e-10	Response to other organism
Process	GO:0098542	21	900	9606	OAS3,NMI,RYDEN,SAMHD1,NLRP6,MX2,OAS2,PARP9,STAT1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,PARP14	OAS3,NMI,C19orf66,SAMHD1,NLRP6,MX2,OAS2,PARP9,STAT1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,PARP14	1.41e-13	1.81e-10	Defense response to other organism
Process	GO:0006955	26	1588	9606	OAS3,NMI,RYDEN,SAMHD1,ERAP1,NLRP6,MX2,OAS2,TAP1,PARP9,STAT1,IFI44,IFI44L,DPP7,IFIT1,IFIT3,IFIT2,TAP2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,PARP14	OAS3,NMI,C19orf66,SAMHD1,ERAP1,NLRP6,MX2,OAS2,TAP1,PARP9,STAT1,IFI44,IFI44L,DPP7,IFIT1,IFIT3,IFIT2,TAP2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,PARP14	2.28e-13	2.44e-10	Immune response
Process	GO:0006952	23	1296	9606	OAS3,NMI,RYDEN,SAMHD1,NLRP6,MX2,OAS2,TAP1,PARP9,STAT1,PTGS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,PARP14	OAS3,NMI,C19orf66,SAMHD1,NLRP6,MX2,OAS2,TAP1,PARP9,STAT1,PTGS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,PARP14	1.87e-12	1.84e-09	Defense response
Process	GO:0045071	8	61	9606	OAS3,RYDEN,OAS2,IFIT1,ISG15,MX1,IFITM3,OAS1	OAS3,C19orf66,OAS2,IFIT1,ISG15,MX1,IFITM3,OAS1	3.4e-11	3.12e-08	Negative regulation of viral genome replication
Process	GO:0048525	9	105	9606	OAS3,RYDEN,OAS2,STAT1,IFIT1,ISG15,MX1,IFITM3,OAS1	OAS3,C19orf66,OAS2,STAT1,IFIT1,ISG15,MX1,IFITM3,OAS1	6.3e-11	5.4e-08	Negative regulation of viral process
Process	GO:0009605	27	2310	9606	OAS3,NMI,RYDEN,SAMHD1,ITGA2,ERAP1,NLRP6,TYMS,MX2,OAS2,PARP9,STAT1,PTGS2,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,PARP14,PALLD	OAS3,NMI,C19orf66,SAMHD1,ITGA2,ERAP1,NLRP6,TYMS,MX2,OAS2,PARP9,STAT1,PTGS2,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,PARP14,PALLD	1.62e-10	1.3e-07	Response to external stimulus
Process	GO:0019221	16	678	9606	OAS3,NMI,SAMHD1,MX2,OAS2,STAT1,PTGS2,IFIT1,IFIT3,IFIT2,ISG15,TRIM22,MX1,IFITM3,OAS1,IFI35	OAS3,NMI,SAMHD1,MX2,OAS2,STAT1,PTGS2,IFIT1,IFIT3,IFIT2,ISG15,TRIM22,MX1,IFITM3,OAS1,IFI35	1.77e-10	1.34e-07	Cytokine-mediated signaling pathway
Process	GO:0002252	18	969	9606	OAS3,RYDEN,SAMHD1,MX2,OAS2,PARP9,STAT1,IFI44L,DPP7,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1	OAS3,C19orf66,SAMHD1,MX2,OAS2,PARP9,STAT1,IFI44L,DPP7,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1	4.53e-10	3.04e-07	Immune effector process
Process	GO:0034097	19	1101	9606	YBX3,OAS3,NMI,RYDEN,SAMHD1,TYMS,MX2,OAS2,STAT1,PTGS2,IFIT1,IFIT3,IFIT2,ISG15,TRIM22,MX1,IFITM3,OAS1,IFI35	YBX3,OAS3,NMI,C19orf66,SAMHD1,TYMS,MX2,OAS2,STAT1,PTGS2,IFIT1,IFIT3,IFIT2,ISG15,TRIM22,MX1,IFITM3,OAS1,IFI35	4.42e-10	3.04e-07	Response to cytokine
Process	GO:0050792	10	215	9606	OAS3,RYDEN,OAS2,STAT1,IFIT1,ISG15,TRIM22,MX1,IFITM3,OAS1	OAS3,C19orf66,OAS2,STAT1,IFIT1,ISG15,TRIM22,MX1,IFITM3,OAS1	1.47e-09	8.57e-07	Regulation of viral process
Process	GO:1903900	9	153	9606	OAS3,RYDEN,OAS2,IFIT1,ISG15,TRIM22,MX1,IFITM3,OAS1	OAS3,C19orf66,OAS2,IFIT1,ISG15,TRIM22,MX1,IFITM3,OAS1	1.47e-09	8.57e-07	Regulation of viral life cycle
Process	GO:0071345	17	1013	9606	YBX3,OAS3,NMI,SAMHD1,MX2,OAS2,STAT1,PTGS2,IFIT1,IFIT3,IFIT2,ISG15,TRIM22,MX1,IFITM3,OAS1,IFI35	YBX3,OAS3,NMI,SAMHD1,MX2,OAS2,STAT1,PTGS2,IFIT1,IFIT3,IFIT2,ISG15,TRIM22,MX1,IFITM3,OAS1,IFI35	6.95e-09	3.43e-06	Cellular response to cytokine stimulus
Process	GO:0035455	5	23	9606	MX2,IFIT3,IFIT2,IFITM3,OAS1	MX2,IFIT3,IFIT2,IFITM3,OAS1	2.1e-08	9.98e-06	Response to interferon-alpha
Process	GO:0006950	29	3485	9606	YBX3,OAS3,NMI,RYDEN,SAMHD1,UBE2L6,IGFBP7,ITGA2,NLRP6,HNRNPM,MX2,OAS2,TAP1,PARP9,STAT1,PTGS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,PARP14,PTK7	YBX3,OAS3,NMI,C19orf66,SAMHD1,UBE2L6,IGFBP7,ITGA2,NLRP6,HNRNPM,MX2,OAS2,TAP1,PARP9,STAT1,PTGS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,PARP14,PTK7	6.65e-08	3.05e-05	Response to stress
Process	GO:0034341	8	182	9606	OAS3,NMI,RYDEN,OAS2,STAT1,TRIM22,IFITM3,OAS1	OAS3,NMI,C19orf66,OAS2,STAT1,TRIM22,IFITM3,OAS1	1.11e-07	4.91e-05	Response to interferon-gamma
Process	GO:0060333	6	70	9606	OAS3,NMI,OAS2,STAT1,TRIM22,OAS1	OAS3,NMI,OAS2,STAT1,TRIM22,OAS1	1.17e-07	5.01e-05	Interferon-gamma-mediated signaling pathway
Process	GO:0010033	25	3011	9606	YBX3,OAS3,NMI,RYDEN,SAMHD1,IGFBP7,ITGA2,TYMS,HNRNPM,MX2,OAS2,STAT1,PTGS2,IFIT1,IFIT3,IFIT2,ISG15,ASPH,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,PTK7	YBX3,OAS3,NMI,C19orf66,SAMHD1,IGFBP7,ITGA2,TYMS,HNRNPM,MX2,OAS2,STAT1,PTGS2,IFIT1,IFIT3,IFIT2,ISG15,ASPH,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,PTK7	9.94e-07	0.0004	Response to organic substance
Process	GO:0071310	22	2369	9606	YBX3,OAS3,NMI,SAMHD1,IGFBP7,ITGA2,HNRNPM,MX2,OAS2,STAT1,PTGS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,PTK7	YBX3,OAS3,NMI,SAMHD1,IGFBP7,ITGA2,HNRNPM,MX2,OAS2,STAT1,PTGS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,PTK7	9.61e-07	0.0004	Cellular response to organic substance
Process	GO:0016032	12	776	9606	RYDEN,SP110,SAMHD1,ITGA2,TAP1,STAT1,IFIT1,TAP2,RTN3,ISG15,DDX58,TRIM22	C19orf66,SP110,SAMHD1,ITGA2,TAP1,STAT1,IFIT1,TAP2,RTN3,ISG15,DDX58,TRIM22	3.83e-06	0.0015	Viral process
Process	GO:0061025	6	136	9606	NAPG,MX2,TAP1,TAP2,SAMD9,MX1	NAPG,MX2,TAP1,TAP2,SAMD9,MX1	4.68e-06	0.0018	Membrane fusion
Process	GO:0031347	11	674	9606	NMI,SAMHD1,ITGA2,ERAP1,NLRP6,PARP9,STAT1,PTGS2,IFIT1,DDX58,PARP14	NMI,SAMHD1,ITGA2,ERAP1,NLRP6,PARP9,STAT1,PTGS2,IFIT1,DDX58,PARP14	6.23e-06	0.0022	Regulation of defense response
Process	GO:0060700	3	9	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	5.86e-06	0.0022	Regulation of ribonuclease activity
Process	GO:0019885	3	10	9606	ERAP1,TAP1,TAP2	ERAP1,TAP1,TAP2	7.6e-06	0.0026	Antigen processing and presentation of endogenous peptide antigen via mhc class i
Process	GO:0070887	23	2919	9606	YBX3,OAS3,NMI,SAMHD1,IGFBP7,ITGA2,HNRNPM,MX2,OAS2,STAT1,PTGS2,IFIT1,IFIT3,IFIT2,ISG15,ASPH,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,PTK7	YBX3,OAS3,NMI,SAMHD1,IGFBP7,ITGA2,HNRNPM,MX2,OAS2,STAT1,PTGS2,IFIT1,IFIT3,IFIT2,ISG15,ASPH,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,PTK7	8.33e-06	0.0028	Cellular response to chemical stimulus
Process	GO:0032480	4	45	9606	NMI,UBE2L6,ISG15,DDX58	NMI,UBE2L6,ISG15,DDX58	1.51e-05	0.0046	Negative regulation of type i interferon production
Process	GO:0035457	3	13	9606	IFIT3,IFIT2,OAS1	IFIT3,IFIT2,OAS1	1.48e-05	0.0046	Cellular response to interferon-alpha
Process	GO:0002831	8	406	9606	NMI,SAMHD1,ERAP1,PARP9,STAT1,IFIT1,DDX58,PARP14	NMI,SAMHD1,ERAP1,PARP9,STAT1,IFIT1,DDX58,PARP14	3.59e-05	0.0105	Regulation of response to biotic stimulus
Process	GO:0007166	19	2325	9606	OAS3,NMI,SAMHD1,ITGA2,HNRNPM,MX2,OAS2,STAT1,PTGS2,IFIT1,IFIT3,IFIT2,ISG15,TRIM22,MX1,IFITM3,OAS1,IFI35,PTK7	OAS3,NMI,SAMHD1,ITGA2,HNRNPM,MX2,OAS2,STAT1,PTGS2,IFIT1,IFIT3,IFIT2,ISG15,TRIM22,MX1,IFITM3,OAS1,IFI35,PTK7	4.31e-05	0.0123	Cell surface receptor signaling pathway
Process	GO:0032479	5	130	9606	NMI,UBE2L6,STAT1,ISG15,DDX58	NMI,UBE2L6,STAT1,ISG15,DDX58	5.76e-05	0.0161	Regulation of type i interferon production
Process	GO:0060334	3	26	9606	PARP9,STAT1,PARP14	PARP9,STAT1,PARP14	9.38e-05	0.0246	Regulation of interferon-gamma-mediated signaling pathway
Process	GO:0050688	4	81	9606	PARP9,STAT1,IFIT1,DDX58	PARP9,STAT1,IFIT1,DDX58	0.00013	0.0335	Regulation of defense response to virus
Process	GO:0046967	2	4	9606	TAP1,TAP2	TAP1,TAP2	0.00014	0.0338	Cytosol to endoplasmic reticulum transport
Process	GO:0035456	3	31	9606	RYDEN,STAT1,IFITM3	C19orf66,STAT1,IFITM3	0.00015	0.0368	Response to interferon-beta
Process	GO:0002230	3	32	9606	PARP9,STAT1,DDX58	PARP9,STAT1,DDX58	0.00017	0.0395	Positive regulation of defense response to virus by host
Process	GO:0032647	3	32	9606	NMI,STAT1,DDX58	NMI,STAT1,DDX58	0.00017	0.0395	Regulation of interferon-alpha production
Process	GO:0050896	39	8046	9606	YBX3,OAS3,NMI,RYDEN,IPO8,SAMHD1,CAPN5,UBE2L6,IGFBP7,ITGA2,ERAP1,NLRP6,TYMS,HNRNPM,MX2,OAS2,TAP1,PARP9,STAT1,PTGS2,IFI44,IFI44L,DPP7,IFIT1,IFIT3,IFIT2,TAP2,ISG15,ASPH,DDX58,TRIM22,SYNPO,MX1,IFITM3,OAS1,IFI35,PARP14,PTK7,PALLD	YBX3,OAS3,NMI,C19orf66,IPO8,SAMHD1,CAPN5,UBE2L6,IGFBP7,ITGA2,ERAP1,NLRP6,TYMS,HNRNPM,MX2,OAS2,TAP1,PARP9,STAT1,PTGS2,IFI44,IFI44L,DPP7,IFIT1,IFIT3,IFIT2,TAP2,ISG15,ASPH,DDX58,TRIM22,SYNPO,MX1,IFITM3,OAS1,IFI35,PARP14,PTK7,PALLD	0.00017	0.0395	Response to stimulus
Process	GO:1902219	2	5	9606	YBX3,PTGS2	YBX3,PTGS2	0.00019	0.0431	Negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress
Process	GO:0042221	26	4333	9606	YBX3,OAS3,NMI,RYDEN,SAMHD1,IGFBP7,ITGA2,TYMS,HNRNPM,MX2,OAS2,STAT1,PTGS2,IFIT1,IFIT3,IFIT2,ISG15,ASPH,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,PTK7,PALLD	YBX3,OAS3,NMI,C19orf66,SAMHD1,IGFBP7,ITGA2,TYMS,HNRNPM,MX2,OAS2,STAT1,PTGS2,IFIT1,IFIT3,IFIT2,ISG15,ASPH,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,PTK7,PALLD	0.00021	0.0465	Response to chemical
Process	GO:0060759	5	175	9606	SAMHD1,PARP9,STAT1,DDX58,PARP14	SAMHD1,PARP9,STAT1,DDX58,PARP14	0.00022	0.0485	Regulation of response to cytokine stimulus
Component	GO:0005737	54	11428	9606	YBX3,OAS3,NMI,DSTN,NDUFA10,RYDEN,IPO8,SQOR,CAPN5,UBE2L6,IGFBP7,ITGA2,ERAP1,NLRP6,TYMS,NAPG,HNRNPM,SAMD9L,MX2,RAP1GDS1,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,TPM3,IFI44,IFI44L,DPP7,IFIT1,IFIT3,IFIT2,TAP2,ATG2A,RTN3,ISG15,ASPH,DDX58,SAMD9,TRIM22,STT3A,SYNPO,SIL1,MX1,IFITM3,OAS1,IFI35,HELZ2,PARP14,MRPS14,PALLD,EIF4G2,AIFM2	YBX3,OAS3,NMI,DSTN,NDUFA10,C19orf66,IPO8,SQRDL,CAPN5,UBE2L6,IGFBP7,ITGA2,ERAP1,NLRP6,TYMS,NAPG,HNRNPM,SAMD9L,MX2,RAP1GDS1,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,TPM3,IFI44,IFI44L,DPP7,IFIT1,IFIT3,IFIT2,TAP2,ATG2A,RTN3,ISG15,ASPH,DDX58,SAMD9,TRIM22,STT3A,SYNPO,SIL1,MX1,IFITM3,OAS1,IFI35,HELZ2,PARP14,MRPS14,PALLD,EIF4G2,AIFM2	7.76e-08	0.00013	Cytoplasm
Component	GO:0005829	33	5193	9606	YBX3,OAS3,NMI,RYDEN,IPO8,UBE2L6,ERAP1,NLRP6,TYMS,MX2,RAP1GDS1,OAS2,PARP9,UBA3,STAT1,TPM3,DPP7,IFIT1,IFIT3,IFIT2,ATG2A,ISG15,DDX58,SAMD9,TRIM22,SYNPO,MX1,OAS1,IFI35,PARP14,PALLD,EIF4G2,AIFM2	YBX3,OAS3,NMI,C19orf66,IPO8,UBE2L6,ERAP1,NLRP6,TYMS,MX2,RAP1GDS1,OAS2,PARP9,UBA3,STAT1,TPM3,DPP7,IFIT1,IFIT3,IFIT2,ATG2A,ISG15,DDX58,SAMD9,TRIM22,SYNPO,MX1,OAS1,IFI35,PARP14,PALLD,EIF4G2,AIFM2	3e-06	0.0025	Cytosol
Component	GO:0005622	57	14276	9606	YBX3,OAS3,NMI,DSTN,NDUFA10,RYDEN,IPO8,SP110,SQOR,SAMHD1,CAPN5,UBE2L6,IGFBP7,ITGA2,ERAP1,NLRP6,TYMS,NAPG,HNRNPM,SAMD9L,PHF6,MX2,RAP1GDS1,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,TPM3,IFI44,IFI44L,DPP7,IFIT1,IFIT3,IFIT2,TAP2,ATG2A,RTN3,ISG15,ASPH,DDX58,SAMD9,TRIM22,STT3A,SYNPO,SIL1,MX1,IFITM3,OAS1,IFI35,HELZ2,PARP14,MRPS14,PALLD,EIF4G2,AIFM2	YBX3,OAS3,NMI,DSTN,NDUFA10,C19orf66,IPO8,SP110,SQRDL,SAMHD1,CAPN5,UBE2L6,IGFBP7,ITGA2,ERAP1,NLRP6,TYMS,NAPG,HNRNPM,SAMD9L,PHF6,MX2,RAP1GDS1,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,TPM3,IFI44,IFI44L,DPP7,IFIT1,IFIT3,IFIT2,TAP2,ATG2A,RTN3,ISG15,ASPH,DDX58,SAMD9,TRIM22,STT3A,SYNPO,SIL1,MX1,IFITM3,OAS1,IFI35,HELZ2,PARP14,MRPS14,PALLD,EIF4G2,AIFM2	1.26e-05	0.0071	Intracellular
Component	GO:0043227	53	12427	9606	YBX3,OAS3,NMI,DSTN,NDUFA10,RYDEN,IPO8,SP110,SQOR,SAMHD1,CAPN5,UBE2L6,IGFBP7,ITGA2,ERAP1,NLRP6,TYMS,NAPG,HNRNPM,SAMD9L,PHF6,MX2,RAP1GDS1,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,TPM3,DPP7,IFIT3,IFIT2,TAP2,ATG2A,RTN3,ISG15,ASPH,SAMD9,TRIM22,STT3A,SYNPO,SIL1,MX1,IFITM3,OAS1,IFI35,HELZ2,PARP14,MRPS14,PALLD,LIN7A,AIFM2	YBX3,OAS3,NMI,DSTN,NDUFA10,C19orf66,IPO8,SP110,SQRDL,SAMHD1,CAPN5,UBE2L6,IGFBP7,ITGA2,ERAP1,NLRP6,TYMS,NAPG,HNRNPM,SAMD9L,PHF6,MX2,RAP1GDS1,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,TPM3,DPP7,IFIT3,IFIT2,TAP2,ATG2A,RTN3,ISG15,ASPH,SAMD9,TRIM22,STT3A,SYNPO,SIL1,MX1,IFITM3,OAS1,IFI35,HELZ2,PARP14,MRPS14,PALLD,LIN7A,AIFM2	1.55e-05	0.0071	Membrane-bounded organelle
Component	GO:0042825	2	2	9606	TAP1,TAP2	TAP1,TAP2	5.49e-05	0.0162	TAP complex
Component	GO:0043231	48	10761	9606	YBX3,OAS3,NMI,NDUFA10,RYDEN,IPO8,SP110,SQOR,SAMHD1,UBE2L6,IGFBP7,ITGA2,ERAP1,NLRP6,TYMS,NAPG,HNRNPM,PHF6,MX2,RAP1GDS1,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,DPP7,IFIT3,IFIT2,TAP2,ATG2A,RTN3,ISG15,ASPH,SAMD9,TRIM22,STT3A,SYNPO,SIL1,MX1,IFITM3,OAS1,IFI35,HELZ2,PARP14,MRPS14,PALLD,AIFM2	YBX3,OAS3,NMI,NDUFA10,C19orf66,IPO8,SP110,SQRDL,SAMHD1,UBE2L6,IGFBP7,ITGA2,ERAP1,NLRP6,TYMS,NAPG,HNRNPM,PHF6,MX2,RAP1GDS1,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,DPP7,IFIT3,IFIT2,TAP2,ATG2A,RTN3,ISG15,ASPH,SAMD9,TRIM22,STT3A,SYNPO,SIL1,MX1,IFITM3,OAS1,IFI35,HELZ2,PARP14,MRPS14,PALLD,AIFM2	4.78e-05	0.0162	Intracellular membrane-bounded organelle
Component	GO:0043229	52	12528	9606	YBX3,OAS3,NMI,DSTN,NDUFA10,RYDEN,IPO8,SP110,SQOR,SAMHD1,UBE2L6,IGFBP7,ITGA2,ERAP1,NLRP6,TYMS,NAPG,HNRNPM,SAMD9L,PHF6,MX2,RAP1GDS1,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,TPM3,DPP7,IFIT3,IFIT2,TAP2,ATG2A,RTN3,ISG15,ASPH,DDX58,SAMD9,TRIM22,STT3A,SYNPO,SIL1,MX1,IFITM3,OAS1,IFI35,HELZ2,PARP14,MRPS14,PALLD,AIFM2	YBX3,OAS3,NMI,DSTN,NDUFA10,C19orf66,IPO8,SP110,SQRDL,SAMHD1,UBE2L6,IGFBP7,ITGA2,ERAP1,NLRP6,TYMS,NAPG,HNRNPM,SAMD9L,PHF6,MX2,RAP1GDS1,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,TPM3,DPP7,IFIT3,IFIT2,TAP2,ATG2A,RTN3,ISG15,ASPH,DDX58,SAMD9,TRIM22,STT3A,SYNPO,SIL1,MX1,IFITM3,OAS1,IFI35,HELZ2,PARP14,MRPS14,PALLD,AIFM2	8.42e-05	0.0204	Intracellular organelle
Component	GO:0043226	54	13515	9606	YBX3,OAS3,NMI,DSTN,NDUFA10,RYDEN,IPO8,SP110,SQOR,SAMHD1,CAPN5,UBE2L6,IGFBP7,ITGA2,ERAP1,NLRP6,TYMS,NAPG,HNRNPM,SAMD9L,PHF6,MX2,RAP1GDS1,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,TPM3,DPP7,IFIT3,IFIT2,TAP2,ATG2A,RTN3,ISG15,ASPH,DDX58,SAMD9,TRIM22,STT3A,SYNPO,SIL1,MX1,IFITM3,OAS1,IFI35,HELZ2,PARP14,MRPS14,PALLD,LIN7A,AIFM2	YBX3,OAS3,NMI,DSTN,NDUFA10,C19orf66,IPO8,SP110,SQRDL,SAMHD1,CAPN5,UBE2L6,IGFBP7,ITGA2,ERAP1,NLRP6,TYMS,NAPG,HNRNPM,SAMD9L,PHF6,MX2,RAP1GDS1,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,TPM3,DPP7,IFIT3,IFIT2,TAP2,ATG2A,RTN3,ISG15,ASPH,DDX58,SAMD9,TRIM22,STT3A,SYNPO,SIL1,MX1,IFITM3,OAS1,IFI35,HELZ2,PARP14,MRPS14,PALLD,LIN7A,AIFM2	0.00012	0.026	Organelle
Component	GO:0098844	2	5	9606	MX2,MX1	MX2,MX1	0.00019	0.0361	Postsynaptic endocytic zone membrane
Function	GO:0001730	3	3	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	5.4e-07	0.0017	2-5-oligoadenylate synthetase activity
Function	GO:0000166	19	2119	9606	OAS3,SQOR,SAMHD1,NLRP6,TYMS,MX2,OAS2,TAP1,UBA3,IFI44L,TAP2,DDX58,SIL1,MX1,OAS1,HELZ2,PARP14,PTK7,AIFM2	OAS3,SQRDL,SAMHD1,NLRP6,TYMS,MX2,OAS2,TAP1,UBA3,IFI44L,TAP2,DDX58,SIL1,MX1,OAS1,HELZ2,PARP14,PTK7,AIFM2	1.17e-05	0.0189	Nucleotide binding
Function	GO:0003723	16	1649	9606	YBX3,OAS3,RYDEN,SAMHD1,TYMS,HNRNPM,PHF6,OAS2,IFIT1,IFIT3,IFIT2,DDX58,OAS1,HELZ2,MRPS14,EIF4G2	YBX3,OAS3,C19orf66,SAMHD1,TYMS,HNRNPM,PHF6,OAS2,IFIT1,IFIT3,IFIT2,DDX58,OAS1,HELZ2,MRPS14,EIF4G2	2.74e-05	0.0222	RNA binding
TISSUES	BTO:0001489	55	12619	9606	YBX3,OAS3,NMI,DSTN,NDUFA10,RYDEN,IPO8,SP110,SQOR,SAMHD1,CAPN5,UBE2L6,IGFBP7,ITGA2,ERAP1,TYMS,NAPG,HNRNPM,SLC41A3,SAMD9L,PHF6,MX2,RAP1GDS1,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,TPM3,IFI44,IFI44L,DPP7,IFIT1,IFIT3,ATG2A,RTN3,ISG15,ASPH,DDX58,SAMD9,TRIM22,STT3A,SYNPO,SIL1,MX1,IFITM3,OAS1,IFI35,HELZ2,PARP14,PTK7,PALLD,EIF4G2,LIN7A	YBX3,OAS3,NMI,DSTN,NDUFA10,C19orf66,IPO8,SP110,SQRDL,SAMHD1,CAPN5,UBE2L6,IGFBP7,ITGA2,ERAP1,TYMS,NAPG,HNRNPM,SLC41A3,SAMD9L,PHF6,MX2,RAP1GDS1,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,TPM3,IFI44,IFI44L,DPP7,IFIT1,IFIT3,ATG2A,RTN3,ISG15,ASPH,DDX58,SAMD9,TRIM22,STT3A,SYNPO,SIL1,MX1,IFITM3,OAS1,IFI35,HELZ2,PARP14,PTK7,PALLD,EIF4G2,LIN7A	1.26e-06	0.0024	Whole body
TISSUES	BTO:0000570	21	2543	9606	YBX3,OAS3,DSTN,SP110,SAMHD1,UBE2L6,ITGA2,ERAP1,HNRNPM,SAMD9L,PHF6,RAP1GDS1,OAS2,TAP1,PTGS2,TPM3,RTN3,OAS1,IFI35,HELZ2,EIF4G2	YBX3,OAS3,DSTN,SP110,SAMHD1,UBE2L6,ITGA2,ERAP1,HNRNPM,SAMD9L,PHF6,RAP1GDS1,OAS2,TAP1,PTGS2,TPM3,RTN3,OAS1,IFI35,HELZ2,EIF4G2	1.21e-05	0.0115	Hematopoietic system
TISSUES	BTO:0003099	21	2593	9606	YBX3,NDUFA10,SAMHD1,IGFBP7,TYMS,HNRNPM,OAS2,UBA3,STAT1,PTGS2,TPM3,IFI44L,ATG2A,SIL1,MX1,IFITM3,OAS1,PARP14,PTK7,PALLD,EIF4G2	YBX3,NDUFA10,SAMHD1,IGFBP7,TYMS,HNRNPM,OAS2,UBA3,STAT1,PTGS2,TPM3,IFI44L,ATG2A,SIL1,MX1,IFITM3,OAS1,PARP14,PTK7,PALLD,EIF4G2	1.64e-05	0.0115	Internal female genital organ
TISSUES	BTO:0000081	34	6107	9606	YBX3,NMI,DSTN,NDUFA10,RYDEN,IPO8,SAMHD1,IGFBP7,ERAP1,TYMS,HNRNPM,SLC41A3,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,TPM3,IFI44L,IFIT1,IFIT3,ATG2A,RTN3,ISG15,DDX58,SIL1,MX1,IFITM3,OAS1,PARP14,PTK7,PALLD,EIF4G2	YBX3,NMI,DSTN,NDUFA10,C19orf66,IPO8,SAMHD1,IGFBP7,ERAP1,TYMS,HNRNPM,SLC41A3,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,TPM3,IFI44L,IFIT1,IFIT3,ATG2A,RTN3,ISG15,DDX58,SIL1,MX1,IFITM3,OAS1,PARP14,PTK7,PALLD,EIF4G2	4.09e-05	0.0158	Reproductive system
TISSUES	BTO:0000089	16	1675	9606	YBX3,OAS3,DSTN,SP110,SAMHD1,ITGA2,ERAP1,HNRNPM,RAP1GDS1,OAS2,TAP1,PTGS2,TPM3,OAS1,IFI35,EIF4G2	YBX3,OAS3,DSTN,SP110,SAMHD1,ITGA2,ERAP1,HNRNPM,RAP1GDS1,OAS2,TAP1,PTGS2,TPM3,OAS1,IFI35,EIF4G2	3.32e-05	0.0158	Blood
TISSUES	BTO:0000042	57	14895	9606	YBX3,OAS3,NMI,DSTN,NDUFA10,RYDEN,IPO8,SP110,SQOR,SAMHD1,CAPN5,UBE2L6,IGFBP7,ITGA2,ERAP1,TYMS,NAPG,HNRNPM,SLC41A3,SAMD9L,PHF6,MX2,RAP1GDS1,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,TPM3,IFI44,IFI44L,DPP7,IFIT1,IFIT3,ATG2A,RTN3,ISG15,ASPH,DDX58,SAMD9,TRIM22,STT3A,SYNPO,SIL1,MX1,IFITM3,OAS1,IFI35,HELZ2,PARP14,PTK7,MRPS14,PALLD,EIF4G2,LIN7A,AIFM2	YBX3,OAS3,NMI,DSTN,NDUFA10,C19orf66,IPO8,SP110,SQRDL,SAMHD1,CAPN5,UBE2L6,IGFBP7,ITGA2,ERAP1,TYMS,NAPG,HNRNPM,SLC41A3,SAMD9L,PHF6,MX2,RAP1GDS1,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,TPM3,IFI44,IFI44L,DPP7,IFIT1,IFIT3,ATG2A,RTN3,ISG15,ASPH,DDX58,SAMD9,TRIM22,STT3A,SYNPO,SIL1,MX1,IFITM3,OAS1,IFI35,HELZ2,PARP14,PTK7,MRPS14,PALLD,EIF4G2,LIN7A,AIFM2	9.93e-05	0.0296	Animal
TISSUES	BTO:0000083	32	5799	9606	YBX3,NMI,DSTN,NDUFA10,RYDEN,IPO8,SAMHD1,IGFBP7,ERAP1,TYMS,HNRNPM,SLC41A3,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,TPM3,IFI44L,ATG2A,RTN3,ISG15,DDX58,SIL1,MX1,IFITM3,OAS1,PARP14,PTK7,PALLD,EIF4G2	YBX3,NMI,DSTN,NDUFA10,C19orf66,IPO8,SAMHD1,IGFBP7,ERAP1,TYMS,HNRNPM,SLC41A3,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,TPM3,IFI44L,ATG2A,RTN3,ISG15,DDX58,SIL1,MX1,IFITM3,OAS1,PARP14,PTK7,PALLD,EIF4G2	0.00011	0.0296	Female reproductive system
TISSUES	BTO:0000203	14	1436	9606	YBX3,DSTN,SQOR,SAMHD1,IGFBP7,OAS2,PTGS2,TPM3,IFI44,ASPH,TRIM22,STT3A,PARP14,EIF4G2	YBX3,DSTN,SQRDL,SAMHD1,IGFBP7,OAS2,PTGS2,TPM3,IFI44,ASPH,TRIM22,STT3A,PARP14,EIF4G2	9.33e-05	0.0296	Respiratory system
TISSUES	BTO:0003091	35	6716	9606	YBX3,NMI,DSTN,NDUFA10,RYDEN,IPO8,SAMHD1,IGFBP7,ERAP1,TYMS,HNRNPM,SLC41A3,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,TPM3,IFI44L,IFIT1,IFIT3,ATG2A,RTN3,ISG15,DDX58,SYNPO,SIL1,MX1,IFITM3,OAS1,PARP14,PTK7,PALLD,EIF4G2	YBX3,NMI,DSTN,NDUFA10,C19orf66,IPO8,SAMHD1,IGFBP7,ERAP1,TYMS,HNRNPM,SLC41A3,OAS2,TAP1,PARP9,UBA3,STAT1,PTGS2,TPM3,IFI44L,IFIT1,IFIT3,ATG2A,RTN3,ISG15,DDX58,SYNPO,SIL1,MX1,IFITM3,OAS1,PARP14,PTK7,PALLD,EIF4G2	0.00012	0.0296	Urogenital system
TISSUES	BTO:0000522	34	6602	9606	YBX3,DSTN,NDUFA10,RYDEN,IPO8,SQOR,SAMHD1,CAPN5,UBE2L6,IGFBP7,ITGA2,ERAP1,HNRNPM,SLC41A3,PHF6,PARP9,STAT1,TPM3,DPP7,IFIT1,RTN3,ISG15,ASPH,DDX58,STT3A,SYNPO,SIL1,IFITM3,OAS1,PARP14,PTK7,PALLD,EIF4G2,LIN7A	YBX3,DSTN,NDUFA10,C19orf66,IPO8,SQRDL,SAMHD1,CAPN5,UBE2L6,IGFBP7,ITGA2,ERAP1,HNRNPM,SLC41A3,PHF6,PARP9,STAT1,TPM3,DPP7,IFIT1,RTN3,ISG15,ASPH,DDX58,STT3A,SYNPO,SIL1,IFITM3,OAS1,PARP14,PTK7,PALLD,EIF4G2,LIN7A	0.00023	0.0398	Gland
TISSUES	BTO:0001488	32	6036	9606	YBX3,DSTN,NDUFA10,RYDEN,IPO8,SQOR,SAMHD1,CAPN5,UBE2L6,IGFBP7,ITGA2,ERAP1,HNRNPM,SLC41A3,PHF6,PARP9,STAT1,TPM3,DPP7,IFIT1,RTN3,ISG15,ASPH,DDX58,STT3A,SIL1,IFITM3,OAS1,PARP14,PTK7,PALLD,EIF4G2	YBX3,DSTN,NDUFA10,C19orf66,IPO8,SQRDL,SAMHD1,CAPN5,UBE2L6,IGFBP7,ITGA2,ERAP1,HNRNPM,SLC41A3,PHF6,PARP9,STAT1,TPM3,DPP7,IFIT1,RTN3,ISG15,ASPH,DDX58,STT3A,SIL1,IFITM3,OAS1,PARP14,PTK7,PALLD,EIF4G2	0.00025	0.0398	Endocrine gland
DISEASES	DOID:0060861	5	8	9606	OAS3,OAS2,DDX58,MX1,OAS1	OAS3,OAS2,DDX58,MX1,OAS1	2.84e-10	1.24e-06	Microphthalmia with limb anomalies
Keyword	KW-0051	17	127	9606	OAS3,RYDEN,SAMHD1,MX2,OAS2,PARP9,STAT1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1	OAS3,C19orf66,SAMHD1,MX2,OAS2,PARP9,STAT1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1	5.8e-23	3.92e-20	Antiviral defense
Keyword	KW-0391	18	522	9606	OAS3,SAMHD1,ERAP1,NLRP6,MX2,OAS2,TAP1,PARP9,IFIT1,IFIT3,IFIT2,TAP2,ISG15,DDX58,MX1,IFITM3,OAS1,PARP14	OAS3,SAMHD1,ERAP1,NLRP6,MX2,OAS2,TAP1,PARP9,IFIT1,IFIT3,IFIT2,TAP2,ISG15,DDX58,MX1,IFITM3,OAS1,PARP14	1.96e-14	6.61e-12	Immunity
Keyword	KW-0399	15	324	9606	OAS3,SAMHD1,NLRP6,MX2,OAS2,PARP9,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1,PARP14	OAS3,SAMHD1,NLRP6,MX2,OAS2,PARP9,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1,PARP14	7.04e-14	1.59e-11	Innate immunity
Keyword	KW-0945	11	534	9606	SP110,SAMHD1,ITGA2,TAP1,STAT1,IFIT1,TAP2,RTN3,ISG15,DDX58,TRIM22	SP110,SAMHD1,ITGA2,TAP1,STAT1,IFIT1,TAP2,RTN3,ISG15,DDX58,TRIM22	6.84e-07	0.00012	Host-virus interaction
KEGG	hsa05160	8	156	9606	OAS3,MX2,OAS2,STAT1,IFIT1,DDX58,MX1,OAS1	OAS3,MX2,OAS2,STAT1,IFIT1,DDX58,MX1,OAS1	3.54e-08	1.19e-05	Hepatitis C
KEGG	hsa05169	8	193	9606	OAS3,OAS2,TAP1,STAT1,TAP2,ISG15,DDX58,OAS1	OAS3,OAS2,TAP1,STAT1,TAP2,ISG15,DDX58,OAS1	1.71e-07	2.87e-05	Epstein-Barr virus infection
KEGG	hsa05162	7	138	9606	OAS3,MX2,OAS2,STAT1,DDX58,MX1,OAS1	OAS3,MX2,OAS2,STAT1,DDX58,MX1,OAS1	2.89e-07	3.24e-05	Measles
KEGG	hsa05164	7	165	9606	OAS3,MX2,OAS2,STAT1,DDX58,MX1,OAS1	OAS3,MX2,OAS2,STAT1,DDX58,MX1,OAS1	9.18e-07	7.71e-05	Influenza A
KEGG	hsa04621	5	174	9606	OAS3,NLRP6,OAS2,STAT1,OAS1	OAS3,NLRP6,OAS2,STAT1,OAS1	0.00022	0.0146	NOD-like receptor signaling pathway
KEGG	hsa05165	6	325	9606	ITGA2,MX2,STAT1,PTGS2,ISG15,MX1	ITGA2,MX2,STAT1,PTGS2,ISG15,MX1	0.00051	0.0287	Human papillomavirus infection
KEGG	hsa05168	7	479	9606	OAS3,OAS2,TAP1,STAT1,TAP2,DDX58,OAS1	OAS3,OAS2,TAP1,STAT1,TAP2,DDX58,OAS1	0.00068	0.0326	Herpes simplex virus 1 infection
InterPro	IPR002934	3	7	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	3.21e-06	0.0064	Polymerase, nucleotidyl transferase domain
InterPro	IPR006116	3	4	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	9.43e-07	0.0064	2-5OAS/ClassI-CCAase, nucleotidyltransferase domain
InterPro	IPR006117	3	4	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	9.43e-07	0.0064	2-5-oligoadenylate synthetase, C-terminal  conserved site
InterPro	IPR018952	3	4	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	9.43e-07	0.0064	2-5-oligoadenylate synthetase 1, domain 2/C-terminal
InterPro	IPR026774	3	4	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	9.43e-07	0.0064	2-5-oligoadenylate synthase
InterPro	IPR043518	3	4	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	9.43e-07	0.0064	2-5-oligoadenylate synthetase, N-terminal conserved site
Pfam	PF10421	3	4	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	9.43e-07	0.0032	2-5-oligoadenylate synthetase 1, domain 2, C-terminus 
Pfam	PF01909	3	11	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	9.65e-06	0.0166	Nucleotidyltransferase domain
PMID	PMID:31665046	20	76	9606	OAS3,RYDEN,UBE2L6,SAMD9L,MX2,OAS2,PARP9,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,SAMD9,TRIM22,MX1,OAS1,IFI35,HELZ2	OAS3,C19orf66,UBE2L6,SAMD9L,MX2,OAS2,PARP9,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,SAMD9,TRIM22,MX1,OAS1,IFI35,HELZ2	2.67e-32	1.05e-25	(2019) Identifying novel biomarkers of the pediatric influenza infection by weighted co-expression network analysis.
PMID	PMID:34771433	16	38	9606	OAS3,SAMHD1,ERAP1,SAMD9L,MX2,OAS2,PARP9,STAT1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1,PARP14	OAS3,SAMHD1,ERAP1,SAMD9L,MX2,OAS2,PARP9,STAT1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1,PARP14	1.27e-28	2.5e-22	(2021) Multi-Omics Analysis of Glioblastoma Cells Sensitivity to Oncolytic Viruses.
PMID	PMID:35281454	14	34	9606	UBE2L6,MX2,PARP9,STAT1,PTGS2,IFI44,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1,PARP14	UBE2L6,MX2,PARP9,STAT1,PTGS2,IFI44,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1,PARP14	5.41e-25	7.11e-19	(2022) Streptococcus pneumoniae and Influenza A Virus Co-Infection Induces Altered Polyubiquitination in A549 Cells.
PMID	PMID:34160465	14	36	9606	OAS3,SAMHD1,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1	OAS3,SAMHD1,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1	1.05e-24	1.03e-18	(2021) Identification of hub genes, pathways, and related transcription factors in systemic lupus erythematosus: A preliminary bioinformatics analysis.
PMID	PMID:34937051	14	46	9606	UBE2L6,SAMD9L,MX2,OAS2,PARP9,STAT1,IFI44L,IFIT3,ISG15,SAMD9,TRIM22,MX1,OAS1,IFI35	UBE2L6,SAMD9L,MX2,OAS2,PARP9,STAT1,IFI44L,IFIT3,ISG15,SAMD9,TRIM22,MX1,OAS1,IFI35	1.89e-23	1.49e-17	(2022) Local and systemic responses to SARS-CoV-2 infection in children and adults.
PMID	PMID:28805681	16	92	9606	OAS3,MX2,OAS2,PARP9,STAT1,IFI44,IFIT1,ISG15,DDX58,SAMD9,TRIM22,MX1,IFITM3,OAS1,HELZ2,PARP14	OAS3,MX2,OAS2,PARP9,STAT1,IFI44,IFIT1,ISG15,DDX58,SAMD9,TRIM22,MX1,IFITM3,OAS1,HELZ2,PARP14	2.72e-23	1.79e-17	(2017) Influenza Virus Infection, Interferon Response, Viral Counter-Response, and Apoptosis.
PMID	PMID:23781071	14	51	9606	SAMHD1,SAMD9L,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1	SAMHD1,SAMD9L,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1	6.59e-23	3.71e-17	(2013) A short hairpin RNA screen of interferon-stimulated genes identifies a novel negative regulator of the cellular antiviral response.
PMID	PMID:24380850	12	24	9606	OAS3,OAS2,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM3,OAS1,IFI35	OAS3,OAS2,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM3,OAS1,IFI35	2.44e-22	1.2e-16	(2014) Divergent gene expression responses to complicated grief and non-complicated grief.
PMID	PMID:33968942	14	64	9606	OAS3,SAMHD1,UBE2L6,MX2,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,SAMD9,MX1,IFITM3	OAS3,SAMHD1,UBE2L6,MX2,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,SAMD9,MX1,IFITM3	1.07e-21	4.71e-16	(2021) Crosstalk Between SUMO and Ubiquitin-Like Proteins: Implication for Antiviral Defense.
PMID	PMID:34552595	14	65	9606	OAS3,MX2,OAS2,STAT1,IFI44,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35	OAS3,MX2,OAS2,STAT1,IFI44,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35	1.3e-21	4.71e-16	(2021) Tissue-Resident-Memory CD8(+) T Cells Bridge Innate Immune Responses in Neighboring Epithelial Cells to Control Human Genital Herpes.
PMID	PMID:17488182	14	64	9606	OAS3,SAMD9L,MX2,PARP9,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,SAMD9,MX1,OAS1	OAS3,SAMD9L,MX2,PARP9,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,SAMD9,MX1,OAS1	1.07e-21	4.71e-16	(2007) Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma.
PMID	PMID:28806913	12	31	9606	OAS3,MX2,OAS2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1	OAS3,MX2,OAS2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1	2.94e-21	9.68e-16	(2017) Proteomics informed by transcriptomics for characterising differential cellular susceptibility to Nelson Bay orthoreovirus infection.
PMID	PMID:34818375	11	19	9606	OAS3,MX2,OAS2,STAT1,IFI44L,IFIT3,ISG15,DDX58,MX1,OAS1,IFI35	OAS3,MX2,OAS2,STAT1,IFI44L,IFIT3,ISG15,DDX58,MX1,OAS1,IFI35	4.31e-21	1.31e-15	(2021) Ten genes are considered as potential biomarkers for the diagnosis of dermatomyositis.
PMID	PMID:23299892	13	51	9606	OAS3,SAMD9L,OAS2,STAT1,IFI44,IFI44L,IFIT3,IFIT2,ISG15,TRIM22,MX1,OAS1,HELZ2	OAS3,SAMD9L,OAS2,STAT1,IFI44,IFI44L,IFIT3,IFIT2,ISG15,TRIM22,MX1,OAS1,HELZ2	5.91e-21	1.67e-15	(2013) Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans.
PMID	PMID:34490145	13	52	9606	OAS3,MX2,OAS2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1,IFI35	OAS3,MX2,OAS2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1,IFI35	7.37e-21	1.94e-15	(2021) Transcriptional Profiling of Human Peripheral Blood Mononuclear Cells Stimulated by Mycobacterium tuberculosis PPE57 Identifies Characteristic Genes Associated With Type I Interferon Signaling.
PMID	PMID:35075430	12	35	9606	OAS3,SAMD9L,OAS2,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM3,OAS1	OAS3,SAMD9L,OAS2,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM3,OAS1	9.94e-21	2.45e-15	(2022) Bioinformatic Analysis Identifies Biomarkers and Treatment Targets in Primary Sjoegrens Syndrome Patients with Fatigue.
PMID	PMID:31937643	12	35	9606	OAS3,MX2,OAS2,STAT1,IFI44L,IFIT1,ISG15,DDX58,MX1,IFITM3,OAS1,IFI35	OAS3,MX2,OAS2,STAT1,IFI44L,IFIT1,ISG15,DDX58,MX1,IFITM3,OAS1,IFI35	9.94e-21	2.45e-15	(2020) Cell-to-Cell Variation in Defective Virus Expression and Effects on Host Responses during Influenza Virus Infection.
PMID	PMID:30336493	12	36	9606	UBE2L6,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1	UBE2L6,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1	1.32e-20	2.9e-15	(2018) Type 1 interferon-inducible gene expression in QuantiFERON Gold TB-positive uveitis: A tool to stratify a high versus low risk of active tuberculosis?
PMID	PMID:26695443	12	36	9606	UBE2L6,OAS2,PARP9,STAT1,IFI44,IFI44L,IFIT1,IFIT3,ISG15,SAMD9,MX1,OAS1	UBE2L6,OAS2,PARP9,STAT1,IFI44,IFI44L,IFIT1,IFIT3,ISG15,SAMD9,MX1,OAS1	1.32e-20	2.9e-15	(2016) Activation of IFNSTAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer.
PMID	PMID:22703193	14	79	9606	SAMHD1,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1,IFI35	SAMHD1,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1,IFI35	1.51e-20	2.97e-15	(2012) Transcriptome analysis of the interferon-signature defining the autoimmune process of Sjoegrens syndrome.
PMID	PMID:35086375	12	37	9606	OAS3,MX2,OAS2,STAT1,IFI44,IFI44L,IFIT1,ISG15,TRIM22,MX1,OAS1,IFI35	OAS3,MX2,OAS2,STAT1,IFI44,IFI44L,IFIT1,ISG15,TRIM22,MX1,OAS1,IFI35	1.75e-20	3.28e-15	(2022) Integrated analysis of differentially expressed genes, differentially methylated genes, and natural compounds in hepatitis C virus-induced cirrhosis.
PMID	PMID:32164778	12	37	9606	OAS3,MX2,OAS2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM3,OAS1,IFI35	OAS3,MX2,OAS2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM3,OAS1,IFI35	1.75e-20	3.28e-15	(2020) Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis.
PMID	PMID:25377889	12	37	9606	OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1,IFI35	OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1,IFI35	1.75e-20	3.28e-15	(2014) Lassa and Marburg viruses elicit distinct host transcriptional responses early after infection.
PMID	PMID:31465999	13	57	9606	OAS3,SAMHD1,MX2,STAT1,IFI44,IFIT1,IFIT3,ISG15,DDX58,SAMD9,TRIM22,MX1,OAS1	OAS3,SAMHD1,MX2,STAT1,IFI44,IFIT1,IFIT3,ISG15,DDX58,SAMD9,TRIM22,MX1,OAS1	2.11e-20	3.46e-15	(2019) Virus- and Interferon Alpha-Induced Transcriptomes of Cells from the Microbat Myotis daubentonii.
PMID	PMID:27791205	13	57	9606	UBE2L6,OAS2,PARP9,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,SAMD9,MX1,OAS1,PARP14	UBE2L6,OAS2,PARP9,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,SAMD9,MX1,OAS1,PARP14	2.11e-20	3.46e-15	(2016) Intracellular STING inactivation sensitizes breast cancer cells to genotoxic agents.
PMID	PMID:23847613	13	58	9606	SAMHD1,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,DDX58,MX1,IFITM3,OAS1,IFI35	SAMHD1,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,DDX58,MX1,IFITM3,OAS1,IFI35	2.57e-20	3.9e-15	(2013) The Interferon-Signature of Sjoegrens Syndrome: How Unique Biomarkers Can Identify Underlying Inflammatory and Immunopathological Mechanisms of Specific Diseases.
PMID	PMID:18648529	14	83	9606	OAS3,UBE2L6,MX2,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1	OAS3,UBE2L6,MX2,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1	2.82e-20	4.11e-15	(2008) Type I interferon: potential therapeutic target for psoriasis?
PMID	PMID:34997119	15	113	9606	OAS3,MX2,OAS2,PARP9,STAT1,TPM3,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,TRIM22,MX1,OAS1	OAS3,MX2,OAS2,PARP9,STAT1,TPM3,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,TRIM22,MX1,OAS1	2.93e-20	4.13e-15	(2022) Transcriptomes of peripheral blood mononuclear cells from juvenile dermatomyositis patients show elevated inflammation even when clinically inactive.
PMID	PMID:31949544	11	25	9606	OAS2,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,SAMD9,MX1,IFITM3,OAS1	OAS2,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,SAMD9,MX1,IFITM3,OAS1	4.68e-20	6.26e-15	(2019) Bioinformatics Analysis of Potential Key Genes in Trastuzumab-Resistant Gastric Cancer.
PMID	PMID:22483866	13	61	9606	OAS3,IGFBP7,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,OAS1	OAS3,IGFBP7,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,OAS1	4.6e-20	6.26e-15	(2012) The conserved Cockayne syndrome B-piggyBac fusion protein (CSB-PGBD3) affects DNA repair and induces both interferon-like and innate antiviral responses in CSB-null cells.
PMID	PMID:30400182	13	62	9606	OAS3,UBE2L6,MX2,OAS2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1,PARP14	OAS3,UBE2L6,MX2,OAS2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1,PARP14	5.56e-20	7.07e-15	(2018) Transcriptomics Reveal Antiviral Gene Induction in the Egyptian Rousette Bat Is Antagonized In Vitro by Marburg Virus Infection.
PMID	PMID:28701698	15	119	9606	OAS3,SAMHD1,MX2,OAS2,STAT1,IFI44,IFI44L,IFIT3,IFIT2,ISG15,TRIM22,MX1,IFITM3,OAS1,IFI35	OAS3,SAMHD1,MX2,OAS2,STAT1,IFI44,IFI44L,IFIT3,IFIT2,ISG15,TRIM22,MX1,IFITM3,OAS1,IFI35	5.99e-20	7.39e-15	(2017) Global Mapping of the Macrophage-HIV-1 Transcriptome Reveals that Productive Infection Induces Remodeling of Host Cell DNA and Chromatin.
PMID	PMID:34372578	15	120	9606	OAS3,SAMHD1,UBE2L6,MX2,OAS2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1,HELZ2	OAS3,SAMHD1,UBE2L6,MX2,OAS2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1,HELZ2	6.72e-20	7.68e-15	(2021) Immunity and Viral Infections: Modulating Antiviral Response via CRISPR-Cas Systems.
PMID	PMID:32325933	12	42	9606	MX2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1	MX2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1	6.42e-20	7.68e-15	(2020) RNAseq Reveals the Contribution of Interferon Stimulated Genes to the Increased Host Defense and Decreased PPR Viral Replication in Cattle.
PMID	PMID:24713352	12	42	9606	OAS3,SAMHD1,OAS2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1	OAS3,SAMHD1,OAS2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1	6.42e-20	7.68e-15	(2014) Interferon-stimulated genes: roles in viral pathogenesis.
PMID	PMID:29880853	13	64	9606	MX2,PARP9,STAT1,IFI44L,IFIT1,IFIT3,ISG15,DDX58,MX1,IFITM3,OAS1,IFI35,PARP14	MX2,PARP9,STAT1,IFI44L,IFIT1,IFIT3,ISG15,DDX58,MX1,IFITM3,OAS1,IFI35,PARP14	8.03e-20	8.8e-15	(2018) Immunoprofiles of human Sertoli cells infected with Zika virus reveals unique insights into host-pathogen crosstalk.
PMID	PMID:32276512	11	28	9606	OAS3,OAS2,STAT1,IFI44L,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1	OAS3,OAS2,STAT1,IFI44L,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1	1.3e-19	1.38e-14	(2020) 2, 5-Oligoadenylate Synthetase 2 (OAS2) Inhibits Zika Virus Replication through Activation of Type Iota IFN Signaling Pathway.
PMID	PMID:30581389	12	47	9606	MX2,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1	MX2,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1	2.07e-19	2.15e-14	(2018) Immunomodulatory Properties of DNA Hypomethylating Agents: Selecting the Optimal Epigenetic Partner for Cancer Immunotherapy.
PMID	PMID:24528865	11	30	9606	OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1	OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1	2.43e-19	2.46e-14	(2014) Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness.
PMID	PMID:33142113	13	72	9606	OAS3,MX2,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1	OAS3,MX2,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1	3.17e-19	3.13e-14	(2020) Three-Dimensional Human Alveolar Stem Cell Culture Models Reveal Infection Response to SARS-CoV-2.
PMID	PMID:23369858	12	50	9606	OAS3,IGFBP7,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,OAS1	OAS3,IGFBP7,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,OAS1	3.97e-19	3.82e-14	(2013) What role (if any) does the highly conserved CSB-PGBD3 fusion protein play in Cockayne syndrome?
PMID	PMID:32899429	15	137	9606	YBX3,OAS3,MX2,OAS2,STAT1,PTGS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1	YBX3,OAS3,MX2,OAS2,STAT1,PTGS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1	4.22e-19	3.96e-14	(2020) LncRNAs in the Type I Interferon Antiviral Response.
PMID	PMID:28106799	11	32	9606	OAS3,SAMHD1,MX2,OAS2,STAT1,IFIT1,IFIT3,ISG15,DDX58,MX1,OAS1	OAS3,SAMHD1,MX2,OAS2,STAT1,IFIT1,IFIT3,ISG15,DDX58,MX1,OAS1	4.41e-19	4.04e-14	(2017) RNA Editing, ADAR1, and the Innate Immune Response.
PMID	PMID:32508817	12	51	9606	OAS3,MX2,OAS2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM3,OAS1,IFI35	OAS3,MX2,OAS2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM3,OAS1,IFI35	4.9e-19	4.39e-14	(2020) Contrasting Inflammatory Signatures in Peripheral Blood and Bronchoalveolar Cells Reveal Compartment-Specific Effects of HIV Infection.
PMID	PMID:31582776	12	51	9606	OAS3,ERAP1,MX2,OAS2,IFI44,ISG15,TRIM22,MX1,IFITM3,OAS1,HELZ2,PARP14	OAS3,ERAP1,MX2,OAS2,IFI44,ISG15,TRIM22,MX1,IFITM3,OAS1,HELZ2,PARP14	4.9e-19	4.39e-14	(2019) Transcriptome Sequencing of Peripheral Blood Mononuclear Cells from Elite Controller-Long Term Non Progressors.
PMID	PMID:34992733	11	33	9606	OAS3,SAMHD1,UBE2L6,MX2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFI35	OAS3,SAMHD1,UBE2L6,MX2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFI35	5.86e-19	5.03e-14	(2022) Global proteomics of fibroblast cells treated with bacterial cyclic dinucleotides, c-di-GMP and c-di-AMP.
PMID	PMID:31058188	11	33	9606	OAS2,PARP9,STAT1,IFI44,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IFI35,PARP14	OAS2,PARP9,STAT1,IFI44,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IFI35,PARP14	5.86e-19	5.03e-14	(2019) What Changed on the Folliculogenesis in the Process of Mouse Ovarian Aging?
PMID	PMID:35326463	12	53	9606	MX2,OAS2,PARP9,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1,OAS1	MX2,OAS2,PARP9,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1,OAS1	7.36e-19	6.05e-14	(2022) Multi-Design Differential Expression Profiling of COVID-19 Lung Autopsy Specimens Reveals Significantly Deregulated Inflammatory Pathways and SFTPC Impaired Transcription.
PMID	PMID:34527935	12	53	9606	SAMD9L,OAS2,PARP9,IFI44,IFI44L,IFIT3,IFIT2,DDX58,TRIM22,OAS1,HELZ2,PARP14	SAMD9L,OAS2,PARP9,IFI44,IFI44L,IFIT3,IFIT2,DDX58,TRIM22,OAS1,HELZ2,PARP14	7.36e-19	6.05e-14	(2021) Investigation of Genes Associated With Atherosclerosis in Patients With Systemic Lupus Erythematosus.
PMID	PMID:29215570	12	53	9606	OAS3,UBE2L6,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,OAS1	OAS3,UBE2L6,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,OAS1	7.36e-19	6.05e-14	(2017) Host Cell Restriction Factors that Limit Influenza A Infection.
PMID	PMID:24678238	12	53	9606	OAS3,UBE2L6,OAS2,IFI44,IFI44L,IFIT1,IFIT3,ISG15,TRIM22,MX1,OAS1,IFI35	OAS3,UBE2L6,OAS2,IFI44,IFI44L,IFIT1,IFIT3,ISG15,TRIM22,MX1,OAS1,IFI35	7.36e-19	6.05e-14	(2012) High-Dimensional Longitudinal Genomic Data: An analysis used for monitoring viral infections.
PMID	PMID:35235083	10	20	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1	9.28e-19	7.04e-14	(2022) Identification of the Hub Genes and the Signaling Pathways in Human iPSC-Cardiomyocytes Infected by SARS-CoV-2.
PMID	PMID:33922087	13	80	9606	OAS3,MX2,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,ISG15,DDX58,MX1,OAS1,IFI35	OAS3,MX2,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,ISG15,DDX58,MX1,OAS1,IFI35	1.09e-18	8.12e-14	(2021) Functional Interfaces, Biological Pathways, and Regulations of Interferon-Related DNA Damage Resistance Signature (IRDS) Genes.
PMID	PMID:34785679	12	55	9606	OAS2,PARP9,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1	OAS2,PARP9,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1	1.09e-18	8.12e-14	(2021) SARS-CoV-2 infection and replication in human gastric organoids.
PMID	PMID:27533247	12	57	9606	SAMD9L,OAS2,PARP9,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,SAMD9,MX1,HELZ2	SAMD9L,OAS2,PARP9,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,SAMD9,MX1,HELZ2	1.6e-18	1.14e-13	(2016) Novel biomarkers of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus.
PMID	PMID:34180358	10	22	9606	OAS3,OAS2,STAT1,IFI44L,IFIT1,IFIT3,ISG15,DDX58,MX1,OAS1	OAS3,OAS2,STAT1,IFI44L,IFIT1,IFIT3,ISG15,DDX58,MX1,OAS1	1.98e-18	1.4e-13	(2021) Potential therapeutic target genes for systemic lupus erythematosus: a bioinformatics analysis.
PMID	PMID:35131898	11	38	9606	MX2,OAS2,STAT1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM3,IFI35	MX2,OAS2,STAT1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM3,IFI35	2.2e-18	1.52e-13	(2022) Differential interferon-alpha subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection.
PMID	PMID:30804934	11	38	9606	OAS3,OAS2,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM3	OAS3,OAS2,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM3	2.2e-18	1.52e-13	(2019) The Long Non-coding RNA NRIR Drives IFN-Response in Monocytes: Implication for Systemic Sclerosis.
PMID	PMID:33450175	12	59	9606	OAS3,SAMHD1,MX2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3	OAS3,SAMHD1,MX2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3	2.31e-18	1.54e-13	(2021) Evolutionary conflicts and adverse effects of antiviral factors.
PMID	PMID:35502341	10	23	9606	MX2,IFI44,IFI44L,IFIT3,IFIT2,DDX58,TRIM22,MX1,IFITM3,OAS1	MX2,IFI44,IFI44L,IFIT3,IFIT2,DDX58,TRIM22,MX1,IFITM3,OAS1	2.84e-18	1.82e-13	(2022) Potential Small Molecules for Therapy of Lupus Nephritis Based on Genetic Effect and Immune Infiltration.
PMID	PMID:32978242	13	87	9606	OAS3,UBE2L6,SAMD9L,OAS2,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,RTN3,ISG15,DDX58,MX1	OAS3,UBE2L6,SAMD9L,OAS2,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,RTN3,ISG15,DDX58,MX1	2.95e-18	1.82e-13	(2020) The myeloid type I interferon response to myocardial infarction begins in bone marrow and is regulated by Nrf2-activated macrophages.
PMID	PMID:26943956	10	23	9606	OAS3,OAS2,STAT1,IFI44L,IFIT1,IFIT2,ISG15,TRIM22,MX1,OAS1	OAS3,OAS2,STAT1,IFI44L,IFIT1,IFIT2,ISG15,TRIM22,MX1,OAS1	2.84e-18	1.82e-13	(2016) A gene expression study denies the ability of 25 candidate biomarkers to predict the interferon-beta treatment response in multiple sclerosis patients.
PMID	PMID:25902143	11	39	9606	OAS3,SAMHD1,MX2,OAS2,STAT1,IFI44,IFIT1,IFIT3,IFIT2,ISG15,MX1	OAS3,SAMHD1,MX2,OAS2,STAT1,IFI44,IFIT1,IFIT3,IFIT2,ISG15,MX1	2.82e-18	1.82e-13	(2015) Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide.
PMID	PMID:18794103	12	60	9606	OAS3,SAMD9L,MX2,OAS2,STAT1,IFI44,IFIT1,IFIT3,IFIT2,MX1,IFITM3,OAS1	OAS3,SAMD9L,MX2,OAS2,STAT1,IFI44,IFIT1,IFIT3,IFIT2,MX1,IFITM3,OAS1	2.76e-18	1.82e-13	(2008) Gene expression profiling reveals similarities between the in vitro and in vivo responses of immune effector cells to IFN-alpha.
PMID	PMID:33290632	11	40	9606	OAS3,OAS2,STAT1,IFI44,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1	OAS3,OAS2,STAT1,IFI44,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1	3.58e-18	2.16e-13	(2021) G-quadruplex-forming nucleic acids interact with splicing factor 3B subunit 2 and suppress innate immune gene expression.
PMID	PMID:30959732	9	12	9606	OAS3,SAMHD1,STAT1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1	OAS3,SAMHD1,STAT1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1	3.56e-18	2.16e-13	(2019) SAMHD1 Enhances Chikungunya and Zika Virus Replication in Human Skin Fibroblasts.
PMID	PMID:31611566	11	40	9606	MX2,OAS2,IFI44,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1	MX2,OAS2,IFI44,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1	3.58e-18	2.16e-13	(2019) Experimental challenge with bovine respiratory syncytial virus in dairy calves: bronchial lymph node transcriptome response.
PMID	PMID:31886250	9	12	9606	OAS3,MX2,OAS2,STAT1,IFI44L,IFIT3,IFIT2,MX1,IFI35	OAS3,MX2,OAS2,STAT1,IFI44L,IFIT3,IFIT2,MX1,IFI35	3.56e-18	2.16e-13	(2019) Identification of Potential Biomarkers and Biological Pathways in Juvenile Dermatomyositis Based on miRNA-mRNA Network.
PMID	PMID:34876791	10	24	9606	OAS3,MX2,OAS2,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,MX1,IFITM3	OAS3,MX2,OAS2,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,MX1,IFITM3	4.01e-18	2.29e-13	(2021) Fusobacterium nucleatum colonization is associated with decreased survival of helicobacter pylori-positive gastric cancer patients.
PMID	PMID:34880855	10	24	9606	OAS3,MX2,OAS2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,MX1,OAS1	OAS3,MX2,OAS2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,MX1,OAS1	4.01e-18	2.29e-13	(2021) Transcriptional Profiling and Machine Learning Unveil a Concordant Biosignature of Type I Interferon-Inducible Host Response Across Nasal Swab and Pulmonary Tissue for COVID-19 Diagnosis.
PMID	PMID:35309355	11	41	9606	SAMHD1,SAMD9L,MX2,STAT1,IFI44,IFI44L,IFIT3,IFIT2,ISG15,TRIM22,MX1	SAMHD1,SAMD9L,MX2,STAT1,IFI44,IFI44L,IFIT3,IFIT2,ISG15,TRIM22,MX1	4.53e-18	2.52e-13	(2022) Abnormal Changes of Monocyte Subsets in Patients With Sjoegrens Syndrome.
PMID	PMID:34367124	11	41	9606	RYDEN,MX2,OAS2,IFI44,IFI44L,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1	C19orf66,MX2,OAS2,IFI44,IFI44L,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1	4.53e-18	2.52e-13	(2021) Comprehensive Transcriptomic Analysis Identifies Novel Antiviral Factors Against Influenza A Virus Infection.
PMID	PMID:34733317	13	91	9606	MX2,OAS2,STAT1,PTGS2,IFI44,IFI44L,IFIT3,ISG15,DDX58,MX1,IFITM3,IFI35,PARP14	MX2,OAS2,STAT1,PTGS2,IFI44,IFI44L,IFIT3,ISG15,DDX58,MX1,IFITM3,IFI35,PARP14	5.03e-18	2.72e-13	(2021) Integrated Network Analysis to Identify Key Modules and Potential Hub Genes Involved in Bovine Respiratory Disease: A Systems Biology Approach.
PMID	PMID:32114504	10	25	9606	OAS3,OAS2,STAT1,IFI44L,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1	OAS3,OAS2,STAT1,IFI44L,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1	5.6e-18	2.99e-13	(2020) Efficient acute and chronic infection of stem cell-derived hepatocytes by hepatitis C virus.
PMID	PMID:34559160	11	42	9606	OAS3,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1,OAS1	OAS3,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1,OAS1	5.71e-18	3e-13	(2021) CXCL10 and its related key genes as potential biomarkers for psoriasis: Evidence from bioinformatics and real-time quantitative polymerase chain reaction.
PMID	PMID:31641281	11	42	9606	OAS3,SAMHD1,OAS2,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1,OAS1	OAS3,SAMHD1,OAS2,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1,OAS1	5.71e-18	3e-13	(2020) A clinical score to guide in decision making for monogenic type I IFNopathies.
PMID	PMID:30621583	13	92	9606	MX2,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1,IFI35	MX2,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1,IFI35	5.73e-18	3e-13	(2019) Bacterial and viral pathogen-associated molecular patterns induce divergent early transcriptomic landscapes in a bovine macrophage cell line.
PMID	PMID:22088795	11	42	9606	OAS3,MX2,OAS2,STAT1,PTGS2,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15	OAS3,MX2,OAS2,STAT1,PTGS2,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15	5.71e-18	3e-13	(2012) Cognitive-behavioral stress management reverses anxiety-related leukocyte transcriptional dynamics.
PMID	PMID:29176033	11	43	9606	OAS3,OAS2,STAT1,PTGS2,IFI44,IFI44L,ISG15,DDX58,MX1,OAS1,IFI35	OAS3,OAS2,STAT1,PTGS2,IFI44,IFI44L,ISG15,DDX58,MX1,OAS1,IFI35	7.15e-18	3.57e-13	(2017) TNFalpha-senescence initiates a STAT-dependent positive feedback loop, leading to a sustained interferon signature, DNA damage, and cytokine secretion.
PMID	PMID:32566414	10	26	9606	OAS3,SAMHD1,OAS2,PTGS2,IFI44,IFIT1,IFIT3,MX1,IFITM3,OAS1	OAS3,SAMHD1,OAS2,PTGS2,IFI44,IFIT1,IFIT3,MX1,IFITM3,OAS1	7.74e-18	3.82e-13	(2020) Host transcriptome-guided drug repurposing for COVID-19 treatment: a meta-analysis based approach.
PMID	PMID:31364746	10	26	9606	OAS3,UBE2L6,MX2,OAS2,IFI44,IFIT1,ISG15,DDX58,SAMD9,OAS1	OAS3,UBE2L6,MX2,OAS2,IFI44,IFIT1,ISG15,DDX58,SAMD9,OAS1	7.74e-18	3.82e-13	(2019) Characteristic genes in THP-1 derived macrophages infected with Mycobacterium tuberculosis H37Rv strain identified by integrating bioinformatics methods.
PMID	PMID:25754082	10	26	9606	OAS3,UBE2L6,OAS2,PARP9,IFIT3,DDX58,TRIM22,OAS1,IFI35,PARP14	OAS3,UBE2L6,OAS2,PARP9,IFIT3,DDX58,TRIM22,OAS1,IFI35,PARP14	7.74e-18	3.82e-13	(2015) Gene networks specific for innate immunity define post-traumatic stress disorder.
PMID	PMID:22694362	11	44	9606	OAS3,SAMHD1,MX2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,SAMD9,MX1	OAS3,SAMHD1,MX2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,SAMD9,MX1	8.92e-18	4.24e-13	(2012) Response of primary human airway epithelial cells to influenza infection: a quantitative proteomic study.
PMID	PMID:33560295	12	68	9606	OAS3,OAS2,IFI44,IFI44L,IFIT1,IFIT2,ISG15,SAMD9,TRIM22,MX1,OAS1,IFI35	OAS3,OAS2,IFI44,IFI44L,IFIT1,IFIT2,ISG15,SAMD9,TRIM22,MX1,OAS1,IFI35	1.06e-17	5e-13	(2021) An OMICs based meta-analysis to support infection state stratification.
PMID	PMID:25703554	11	45	9606	OAS3,OAS2,STAT1,IFI44,IFI44L,IFIT3,IFIT2,ISG15,IFITM3,OAS1,IFI35	OAS3,OAS2,STAT1,IFI44,IFI44L,IFIT3,IFIT2,ISG15,IFITM3,OAS1,IFI35	1.11e-17	5.14e-13	(2015) The human immune response to tuberculosis and its treatment: a view from the blood.
PMID	PMID:25170834	11	45	9606	OAS3,MX2,OAS2,STAT1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1	OAS3,MX2,OAS2,STAT1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1	1.11e-17	5.14e-13	(2014) HIV-1 Vpr induces interferon-stimulated genes in human monocyte-derived macrophages.
PMID	PMID:30665429	13	99	9606	OAS3,MX2,OAS2,IFI44,IFI44L,IFIT1,IFIT3,ISG15,TRIM22,MX1,IFITM3,OAS1,EIF4G2	OAS3,MX2,OAS2,IFI44,IFI44L,IFIT1,IFIT3,ISG15,TRIM22,MX1,IFITM3,OAS1,EIF4G2	1.37e-17	6.23e-13	(2019) An integrative genomic analysis of transcriptional profiles identifies characteristic genes and patterns in HIV-infected long-term non-progressors and elite controllers.
PMID	PMID:25128762	14	135	9606	OAS3,SAMHD1,OAS2,STAT1,IFI44L,IFIT1,IFIT3,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35	OAS3,SAMHD1,OAS2,STAT1,IFI44L,IFIT1,IFIT3,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35	1.46e-17	6.54e-13	(2014) Virus-host mucosal interactions during early SIV rectal transmission.
PMID	PMID:28099485	13	101	9606	OAS3,TYMS,OAS2,PARP9,STAT1,PTGS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,PARP14	OAS3,TYMS,OAS2,PARP9,STAT1,PTGS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,PARP14	1.74e-17	7.73e-13	(2017) Cell-Based Systems Biology Analysis of Human AS03-Adjuvanted H5N1 Avian Influenza Vaccine Responses: A Phase I Randomized Controlled Trial.
PMID	PMID:20709292	13	101	9606	OAS3,UBE2L6,MX2,OAS2,PARP9,STAT1,IFI44,IFIT1,IFIT3,IFIT2,ISG15,MX1,PARP14	OAS3,UBE2L6,MX2,OAS2,PARP9,STAT1,IFI44,IFIT1,IFIT3,IFIT2,ISG15,MX1,PARP14	1.74e-17	7.73e-13	(2010) Peptidoglycan recognition proteins protect mice from experimental colitis by promoting normal gut flora and preventing induction of interferon-gamma.
PMID	PMID:25564224	10	29	9606	MX2,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,OAS1	MX2,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,OAS1	1.92e-17	8.33e-13	(2015) STAT2IRF9 directs a prolonged ISGF3-like transcriptional response and antiviral activity in the absence of STAT1.
PMID	PMID:24065129	10	29	9606	OAS3,MX2,OAS2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,MX1,OAS1	OAS3,MX2,OAS2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,MX1,OAS1	1.92e-17	8.33e-13	(2013) IFNbeta-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage.
PMID	PMID:34944900	11	48	9606	OAS3,OAS2,PARP9,STAT1,IFI44,IFIT1,IFIT3,ISG15,SAMD9,OAS1,IFI35	OAS3,OAS2,PARP9,STAT1,IFI44,IFIT1,IFIT3,ISG15,SAMD9,OAS1,IFI35	2.07e-17	8.77e-13	(2021) Transcription Regulation and Genome Rewiring Governing Sensitivity and Resistance to FOXM1 Inhibition in Breast Cancer.
PMID	PMID:33253099	9	16	9606	OAS3,MX2,OAS2,IFI44,IFI44L,IFIT1,ISG15,MX1,OAS1	OAS3,MX2,OAS2,IFI44,IFI44L,IFIT1,ISG15,MX1,OAS1	2.45e-17	1.03e-12	(2021) Increased expression of interferon regulated and antiviral response genes in CD31+CD102+ lung microvascular endothelial cells from systemic sclerosis patients with end-stage interstitial lung disease.
PMID	PMID:32646047	13	104	9606	OAS3,RYDEN,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM3,OAS1	OAS3,C19orf66,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM3,OAS1	2.47e-17	1.03e-12	(2020) Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.
PMID	PMID:33335862	11	49	9606	OAS3,SAMHD1,MX2,OAS2,STAT1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1	OAS3,SAMHD1,MX2,OAS2,STAT1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1	2.52e-17	1.04e-12	(2020) Extracellular Vesicles in Viral Infections: Two Sides of the Same Coin?
PMID	PMID:34977342	11	50	9606	TYMS,MX2,STAT1,IFI44,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM3,OAS1	TYMS,MX2,STAT1,IFI44,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM3,OAS1	3.07e-17	1.25e-12	(2022) Acquired chemoresistance can lead to increased resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus.
PMID	PMID:34292740	12	76	9606	OAS3,MX2,PARP9,STAT1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1,PARP14	OAS3,MX2,PARP9,STAT1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1,PARP14	3.56e-17	1.43e-12	(2021) DIA-Based Proteome Profiling of Nasopharyngeal Swabs from COVID-19 Patients.
PMID	PMID:34904133	11	51	9606	OAS3,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1,OAS1	OAS3,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1,OAS1	3.73e-17	1.49e-12	(2022) Low levels of CIITA and high levels of SOCS1 predict COVID-19 disease severity in children and adults.
PMID	PMID:25327574	9	17	9606	SAMD9L,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,MX1,OAS1	SAMD9L,STAT1,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,MX1,OAS1	3.74e-17	1.49e-12	(2015) Identification of potential genomic biomarkers for Sjoegrens syndrome using data pooling of gene expression microarrays.
RCTM	HSA-913531	17	196	9606	OAS3,SAMHD1,UBE2L6,MX2,OAS2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,EIF4G2	OAS3,SAMHD1,UBE2L6,MX2,OAS2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,EIF4G2	5.41e-20	1.18e-16	Interferon Signaling
RCTM	HSA-909733	13	69	9606	OAS3,SAMHD1,MX2,OAS2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM3,OAS1,IFI35	OAS3,SAMHD1,MX2,OAS2,STAT1,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM3,OAS1,IFI35	1.93e-19	2.09e-16	Interferon alpha/beta signaling
RCTM	HSA-1169410	11	81	9606	OAS3,UBE2L6,MX2,OAS2,STAT1,IFIT1,ISG15,DDX58,MX1,OAS1,EIF4G2	OAS3,UBE2L6,MX2,OAS2,STAT1,IFIT1,ISG15,DDX58,MX1,OAS1,EIF4G2	3.68e-15	2.66e-12	Antiviral mechanism by IFN-stimulated genes
RCTM	HSA-1280215	19	681	9606	OAS3,SAMHD1,UBE2L6,MX2,OAS2,UBA3,STAT1,PTGS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,EIF4G2	OAS3,SAMHD1,UBE2L6,MX2,OAS2,UBA3,STAT1,PTGS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,EIF4G2	1.27e-13	6.89e-11	Cytokine Signaling in Immune system
RCTM	HSA-1169408	8	73	9606	UBE2L6,MX2,STAT1,IFIT1,ISG15,DDX58,MX1,EIF4G2	UBE2L6,MX2,STAT1,IFIT1,ISG15,DDX58,MX1,EIF4G2	1.27e-10	5.52e-08	ISG15 antiviral mechanism
RCTM	HSA-168256	23	1956	9606	OAS3,SAMHD1,UBE2L6,ERAP1,MX2,OAS2,TAP1,UBA3,STAT1,PTGS2,DPP7,IFIT1,IFIT3,IFIT2,TAP2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,EIF4G2	OAS3,SAMHD1,UBE2L6,ERAP1,MX2,OAS2,TAP1,UBA3,STAT1,PTGS2,DPP7,IFIT1,IFIT3,IFIT2,TAP2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,EIF4G2	6.19e-09	2.24e-06	Immune System
RCTM	HSA-8983711	4	9	9606	OAS3,OAS2,DDX58,OAS1	OAS3,OAS2,DDX58,OAS1	5.53e-08	1.71e-05	OAS antiviral response
RCTM	HSA-877300	5	88	9606	OAS3,OAS2,STAT1,TRIM22,OAS1	OAS3,OAS2,STAT1,TRIM22,OAS1	9.53e-06	0.0026	Interferon gamma signaling
RCTM	HSA-197264	3	19	9606	PARP9,PTGS2,PARP14	PARP9,PTGS2,PARP14	4.01e-05	0.0097	Nicotinamide salvaging
RCTM	HSA-983170	3	25	9606	ERAP1,TAP1,TAP2	ERAP1,TAP1,TAP2	8.43e-05	0.0183	Antigen Presentation: Folding, assembly and peptide loading of class I MHC
RCTM	HSA-936440	3	33	9606	UBE2L6,ISG15,DDX58	UBE2L6,ISG15,DDX58	0.00018	0.0327	Negative regulators of DDX58/IFIH1 signaling
WikiPathways	WP4197	7	23	9606	TAP1,STAT1,IFIT1,IFIT3,MX1,OAS1,IFI35	TAP1,STAT1,IFIT1,IFIT3,MX1,OAS1,IFI35	3.35e-12	2.27e-09	Immune response to tuberculosis
WikiPathways	WP4868	5	31	9606	OAS3,OAS2,STAT1,DDX58,OAS1	OAS3,OAS2,STAT1,DDX58,OAS1	7.9e-08	2.68e-05	Type I interferon induction and signaling during SARS-CoV-2 infection
WikiPathways	WP4880	5	33	9606	OAS3,OAS2,STAT1,DDX58,OAS1	OAS3,OAS2,STAT1,DDX58,OAS1	1.05e-07	2.68e-05	Host-pathogen interaction of human coronaviruses - interferon induction
WikiPathways	WP619	5	37	9606	TAP1,STAT1,IFIT2,ISG15,OAS1	TAP1,STAT1,IFIT2,ISG15,OAS1	1.76e-07	2.98e-05	Type II interferon signaling (IFNG)
WikiPathways	WP4705	3	16	9606	SAMHD1,DDX58,OAS1	SAMHD1,DDX58,OAS1	2.54e-05	0.0034	Pathways of nucleic acid metabolism and innate immune sensing
WikiPathways	WP5039	4	66	9606	STAT1,IFIT2,DDX58,MX1	STAT1,IFIT2,DDX58,MX1	6.22e-05	0.007	SARS-CoV-2 innate immunity evasion and cell-specific immune response
WikiPathways	WP4341	4	71	9606	OAS2,STAT1,IFI44L,ISG15	OAS2,STAT1,IFI44L,ISG15	8.16e-05	0.0079	Non-genomic actions of 1,25 dihydroxyvitamin D3
NetworkNeighborAL	CL:19379	21	83	9606	OAS3,SP110,SAMHD1,UBE2L6,SAMD9L,MX2,OAS2,PARP9,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,PARP14	OAS3,SP110,SAMHD1,UBE2L6,SAMD9L,MX2,OAS2,PARP9,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,PARP14	1.27e-33	5.79e-30	Mixed, incl. interferon alpha/beta signaling, and negative regulation of type i interferon production
NetworkNeighborAL	CL:19382	20	67	9606	OAS3,SP110,UBE2L6,SAMD9L,MX2,OAS2,PARP9,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,PARP14	OAS3,SP110,UBE2L6,SAMD9L,MX2,OAS2,PARP9,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM3,OAS1,IFI35,PARP14	2.99e-33	6.79e-30	Mixed, incl. interferon alpha/beta signaling, and negative regulators of ddx58/ifih1 signaling
NetworkNeighborAL	CL:19389	18	42	9606	OAS3,SP110,UBE2L6,SAMD9L,MX2,OAS2,PARP9,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM3,OAS1,IFI35,PARP14	OAS3,SP110,UBE2L6,SAMD9L,MX2,OAS2,PARP9,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM3,OAS1,IFI35,PARP14	2.72e-32	3.09e-29	Interferon alpha/beta signaling, and ISG15-protein conjugation
NetworkNeighborAL	CL:19385	19	61	9606	OAS3,SP110,UBE2L6,SAMD9L,MX2,OAS2,PARP9,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1,IFI35,PARP14	OAS3,SP110,UBE2L6,SAMD9L,MX2,OAS2,PARP9,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1,IFI35,PARP14	7.03e-32	6.39e-29	Interferon alpha/beta signaling, and Negative regulators of DDX58/IFIH1 signaling
NetworkNeighborAL	CL:19391	15	36	9606	OAS3,UBE2L6,SAMD9L,MX2,OAS2,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM3,OAS1,IFI35	OAS3,UBE2L6,SAMD9L,MX2,OAS2,IFI44,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM3,OAS1,IFI35	8.36e-27	6.33e-24	Interferon alpha/beta signaling, and ISG15-protein conjugation
NetworkNeighborAL	CL:19394	10	21	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1,IFITM3,OAS1,IFI35	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1,IFITM3,OAS1,IFI35	1.37e-18	8.87e-16	Interferon alpha/beta signaling
NetworkNeighborAL	CL:19397	9	16	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1,OAS1,IFI35	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1,OAS1,IFI35	2.45e-17	1.39e-14	Microphthalmia with limb anomalies, and Interferon alpha/beta signaling
NetworkNeighborAL	CL:19399	8	11	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,OAS1,IFI35	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,OAS1,IFI35	3.46e-16	1.75e-13	Mixed, incl. 2-5-oligoadenylate synthetase activity, and nephropathia epidemica
NetworkNeighborAL	CL:19437	5	13	9606	UBE2L6,SAMD9L,IFI44,IFI44L,ISG15	UBE2L6,SAMD9L,IFI44,IFI44L,ISG15	1.87e-09	8.5e-07	Mixed, incl. isg15-protein conjugation, and interferon-induced protein 44 family
NetworkNeighborAL	CL:19402	4	5	9606	OAS2,IFIT1,IFIT3,IFIT2	OAS2,IFIT1,IFIT3,IFIT2	9.83e-09	4.06e-06	Mixed, incl. 4fe-4s single cluster domain, and interferon-induced protein with tetratricopeptide repeats 3
NetworkNeighborAL	CL:19438	3	7	9606	SAMD9L,IFI44,IFI44L	SAMD9L,IFI44,IFI44L	3.21e-06	0.0012	Mixed, incl. interferon-induced protein 44 family, and receptor-transporting protein 4
